These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 34882894)

  • 1. SARS-CoV-2 vaccine-related adverse events in Zimbabwe: The need to strengthen pharmacovigilance in resource-limited settings.
    Murewanhema G; Dzinamarira T; Madziva R; Herrera H; Musuka G
    Pharmacoepidemiol Drug Saf; 2022 Mar; 31(3):379-380. PubMed ID: 34882894
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacovigilance of COVID-19 Vaccines in Pregnant and Lactating Women].
    Silva AM; Ribeiro-Vaz I; Ferreira-da-Silva R; Cruz-Correia R; Polónia J; Bernardes J
    Acta Med Port; 2021 Dec; 34(12):807-809. PubMed ID: 34731595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacovigilance - mRNA COVID-19 vaccines : current state of knowledge on their adverse effects].
    Favre V; Ekobena P; Chtioui H; Rothuizen LE; Livio F; Genton B; Buclin T
    Rev Med Suisse; 2022 Feb; 18(767):190-197. PubMed ID: 35107895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
    Kouamou V; Matarise R; Santos ED; Elose N; Manasa J
    Pan Afr Med J; 2021; 39():255. PubMed ID: 34707756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine post-marketing surveillance: Cardiovascular doctors have a role to play!
    Fournier D; Bouchet A; Lebrun-Vignes B
    Arch Cardiovasc Dis; 2021; 114(8-9):521-523. PubMed ID: 34535416
    [No Abstract]   [Full Text] [Related]  

  • 6. The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination.
    Ralph Edwards I; Lindquist M
    Int J Risk Saf Med; 2020; 31(4):179-180. PubMed ID: 33164947
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing standard safety outcomes for COVID-19 vaccines.
    Buttery JP
    Vaccine; 2021 May; 39(22):3025-3027. PubMed ID: 33888324
    [No Abstract]   [Full Text] [Related]  

  • 8. French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge.
    Lacroix C; Salvo F; Gras-Champel V; Gautier S; Massy N; Valnet-Rabier MB; Grandvuillemin A; Mounier C; Benkebil M; Pariente A; Jonville-Béra AP; Micallef J;
    Therapie; 2021; 76(4):297-303. PubMed ID: 34059351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
    Robertson JS; Loizides U; Adisa A; López de la Rica Manjavacas A; Rodilla V; Strnadova C; Weisser K; Balocco R
    Vaccine; 2022 Jan; 40(1):21-27. PubMed ID: 34844820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves Disease Following the SARS-CoV-2 Vaccine: Case Series.
    Weintraub MA; Ameer B; Sinha Gregory N
    J Investig Med High Impact Case Rep; 2021; 9():23247096211063356. PubMed ID: 34939881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.
    Battegay R; Istampoulouoglou I; Holbro A; Buser A; Hirsiger JR; Eckstein J; Berger CT; Koechlin S; Leuppi-Taegtmeyer AB
    Swiss Med Wkly; 2021 Dec; 151():w30084. PubMed ID: 34908388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.
    Liu Q; Qin C; Liu M; Liu J
    Infect Dis Poverty; 2021 Nov; 10(1):132. PubMed ID: 34776011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection.
    Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V
    J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opening up with COVID-19 passes.
    Bull World Health Organ; 2021 Aug; 99(8):546-547. PubMed ID: 34354308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epidemic in Zimbabwe: Quo Vadis?
    Katsidzira L; Gwaunza L; Hakim JG
    Clin Infect Dis; 2020 Nov; 71(16):2180-2183. PubMed ID: 32392333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
    van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
    Front Immunol; 2021; 12():781280. PubMed ID: 34987509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.
    Fischer JC; Schmidt AG; Bölke E; Keitel V; Feldt T; Jensen B; Freise NF; Häussinger D; Schneider EM; Hermsen D; Kindgen-Milles D; Knoefel WT; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Rox J; Balz V; Maas K; Schmidt L; Grebe O; Ehrhardt A; Gerber PA; Peiper M; Buhren BA; Lichtenberg A; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Aug; 26(1):87. PubMed ID: 34362461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto-immune hepatitis following COVID vaccination.
    Rela M; Jothimani D; Vij M; Rajakumar A; Rammohan A
    J Autoimmun; 2021 Sep; 123():102688. PubMed ID: 34225251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.